---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-033729"
form_type: "8-K"
ticker: "OCEA"
cik: "0001869974"
company_name: "Ocean Biomedical, Inc."
filed_at: "2024-08-23T23:59:59+00:00"
generated_at: "2026-05-31T07:53:35.454877+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Ocean Biomedical receives Nasdaq notice for late 10-Q filing; must file delinquent reports by Oct 14

## Summary
- Received Nasdaq notice on Aug 19, 2024 for failure to file Q2 2024 Form 10-Q on time.
- Must submit compliance plan by Sept 3, 2024; all delinquent reports due by Oct 14, 2024.
- Delinquent reports include Q1 2024 10-Q, Q2 2024 10-Q, and 2023 10-K.
- No immediate effect on listing, but further delays risk delisting.
- Company states it intends to file as soon as practicable.

## SEC filing metadata
- accession: 0001493152-24-033729
- form_type: 8-K
- ticker: OCEA
- cik: 0001869974
- company_name: Ocean Biomedical, Inc.
- filed_at: 2024-08-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1869974/000149315224033729/0001493152-24-033729-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1869974/000149315224033729/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-033729
- JSON: https://secwatch.observer/filing/0001493152-24-033729.json
- Plain text: https://secwatch.observer/filing/0001493152-24-033729.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.